Biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market, according to McKinsey 2017.  They also noted that patent filings are growing at a rate of 25% year on year. 

Out of the customers we spoke to, 92% said they needed sophisticated tools to help them check freedom to operate and novelty for their biological sequences - that's why we built PatSnap Bio. 

In this exclusive webinar, hosted by our Bio team here at PatSnap, we will be discussing: 

  • Critical challenges and needs within the biotechnology industry, identified by our customers  
  • The creation of PatSnap Bio, and the gap it fills for innovators in biotechnology. 
We'll also be showcasing the platform for the first time, and hosting a live Q&A session.